Merit Medical Supports Local Initiative to Help Those with Multiple Sclerosis

Merit employees have joined together to support “Accept the Challenge” Utah Bike MS 2011 a local event to help raise money for programs and services that help people with MS. It is gratifying to be a part of this great project and to feel like we are making a difference for this worthy cause. Larry […]

European Association of Percutaneous Cardiovascular Interventions (EuroPCR)

Merit is preparing to attend one of the largest cardiology trade shows in the world–the EuroPCR that will be held in Paris, May 17-20, 2011. With over 9000 attendees participating in almost 400 sessions over 4 days, there will be plenty of opportunity for Merit to make a positive impression. We’ll have a strong presence […]

Global Embolization Symposium & Technologies Trade Show

Merit recently attended the GEST (Global Embolization Symposium & Technologies) trade show in Paris, France. With the acquisition of BioSphere, the company is now a comprehensive resource for peripheral embolization technologies. Many highly qualified leads were generated at the meeting and there was a lot of interest in our products. Our direct sales representatives in […]

Innovation breeds success

It’s been exciting to see all the new products recently launched here at Merit. At the recent Q1 2011 earnings conference call, CEO Fred Lampropoulos mentioned just a few of the “latest and greatest”. For more than 20 years, the name Merit Medical Systems, Inc. has been synonymous with innovative medical devices used in cardiology […]

Global Embolization Symposium & Technologies Trade Show

Merit will attend the Global Embolization Symposium & Technologies (GEST) trade show next week in Paris, France. With the acquisition of BioSphere, Merit is now a comprehensive resource for peripheral embolization technologies: embolic microspheres such as Embosphere®, EmboGold®, HepaSphere™ and QuadraSphere®, Merit Maestro® and EmboCath® Plus microcatheters, and a broad offering of specialty guide wires […]